Yasuhiro Ogura, Tomohide Hori, Walid M. El Moghazy, Atsushi Yoshizawa, Fumitaka Oike, Akira Mori, Toshimi Kaido, Yasutsugu Takada, Shinji Uemoto – 1 March 2010 – To prevent small‐for‐size syndrome in adult‐to‐adult living donor liver transplantation (A‐LDLT), larger grafts (ie, right lobe grafts) have been selected in many transplant centers. However, some centers are investigating the benefits of portal pressure modulation. Five hundred sixty‐six A‐LDLT procedures using right or left lobe grafts were performed between 1998 and 2008.

Shaun P. Patel – 1 March 2010

Vladimir Krejci, Andrea Vannucci, Alhan Abbas, William Chapman, Ivan M. Kangrga – 1 March 2010 – Arterial pressure–based cardiac output monitors (APCOs) are increasingly used as alternatives to thermodilution. Validation of these evolving technologies in high‐risk surgery is still ongoing. In liver transplantation, FloTrac‐Vigileo (Edwards Lifesciences) has limited correlation with thermodilution, whereas LiDCO Plus (LiDCO Ltd.) has not been tested intraoperatively.

Jessica Walter, Susanne Isabel Orth, Dieter C. Broering – 1 March 2010

Markus Rentsch, Jens Meyer, Joachim Andrassy, Carl‐Ludwig Fischer‐Fröhlich, Christan Rust, Susanna Mueller, Martin Angele, Florian Löhe, Karl‐Walter Jauch, Christian Graeb – 1 March 2010 – The increasing donor organ shortage requires the consideration of any possible organ donor in order to meet the current demand. However, the growing number of long‐term survivors of liver transplantation may create a situation in which former organ recipients may experience brain death with a functioning graft and therefore become organ donors themselves.

Rong‐Qin Zheng, Ren Mao, Jie Ren, Er‐Jiao Xu, Mei Liao, Ping Wang, Min‐Qiang Lu, Yang Yang, Chang‐Jie Cai, Gui‐Hua Chen – 1 March 2010 – Hepatic artery stenosis (HAS) is a common complication in liver transplant patients. Conventional angiography remains the gold standard for diagnosis. Recently, contrast‐enhanced ultrasound (CEUS) has begun providing real‐time angiographic‐like images of vessels and allowing the accurate diagnosis of arterial diseases such as hepatic artery thrombosis.

Salvador Benlloch, Marina Berenguer, Joaquin Primo – 1 March 2010

Abigail E. Mitchell, Heather M. Colvin, R. Palmer Beasley – 22 February 2010 – Despite federal, state, and local public health efforts to prevent and control hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health problems in the United States. About 1%‐2% of the U.S. population has chronic HBV or HCV infections, and each year about 15,000 people die from liver cancer or liver disease related to these preventable infections.

Keishi Sugimachi, Ken Shirabe, Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Yo‐Ichi Yamashita, Kenji Umeda, Kazutoyo Morita, Yoshihiko Maehara – 19 February 2010

Timothy J. S. Cross, Andrew K. Burroughs, Phillip M. Harrison – 19 February 2010